Improvement of renal function after transcatheter aortic valve replacement and its impact on survival

Background: Chronic kidney disease as well as acute kidney injury are associated with adverse outcomes after transcatheter aortic valve replacement (TAVR). However, little is known about the prognostic implications of an improvement in renal function after TAVR. Methods: Renal improvement (RI) was d...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kylies, Dominik (VerfasserIn) , Freitag-Wolf, Sandra (VerfasserIn) , Fulisch, Florian (VerfasserIn) , Seoudy, Hatim (VerfasserIn) , Kuhn, Christian (VerfasserIn) , Kihm, Lars Philipp (VerfasserIn) , Pühler, Thomas (VerfasserIn) , Lutter, Georg (VerfasserIn) , Dempfle, Astrid (VerfasserIn) , Frey, Norbert (VerfasserIn) , Feldkamp, Thorsten (VerfasserIn) , Frank, Derk (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 02 March 2021
In: BMC nephrology
Year: 2021, Jahrgang: 22, Pages: 1-9
ISSN:1471-2369
DOI:10.1186/s12882-021-02274-5
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-021-02274-5
Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.1186/s12882-021-02274-5
Volltext
Verfasserangaben:Dominik Kylies, Sandra Freitag-Wolf, Florian Fulisch, Hatim Seoudy, Christian Kuhn, Lars Philipp Kihm, Thomas Pühler, Georg Lutter, Astrid Dempfle, Norbert Frey, Thorsten Feldkamp and Derk Frank

MARC

LEADER 00000caa a2200000 c 4500
001 1768144702
003 DE-627
005 20230419115908.0
007 cr uuu---uuuuu
008 210831s2021 xx |||||o 00| ||eng c
024 7 |a 10.1186/s12882-021-02274-5  |2 doi 
035 |a (DE-627)1768144702 
035 |a (DE-599)KXP1768144702 
035 |a (OCoLC)1341421053 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kylies, Dominik  |d 1991-  |e VerfasserIn  |0 (DE-588)1132145465  |0 (DE-627)887439012  |0 (DE-576)48864576X  |4 aut 
245 1 0 |a Improvement of renal function after transcatheter aortic valve replacement and its impact on survival  |c Dominik Kylies, Sandra Freitag-Wolf, Florian Fulisch, Hatim Seoudy, Christian Kuhn, Lars Philipp Kihm, Thomas Pühler, Georg Lutter, Astrid Dempfle, Norbert Frey, Thorsten Feldkamp and Derk Frank 
264 1 |c 02 March 2021 
300 |a 9 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 31.08.2021 
520 |a Background: Chronic kidney disease as well as acute kidney injury are associated with adverse outcomes after transcatheter aortic valve replacement (TAVR). However, little is known about the prognostic implications of an improvement in renal function after TAVR. Methods: Renal improvement (RI) was defined as a decrease in postprocedural creatinine in μmol/l of ≥1% compared to its preprocedural baseline value. A propensity score representing the likelihood of RI was calculated to define patient groups which were comparable regarding potential confounders (age, sex, BMI, NYHA classification, STS score, log. EuroSCORE, history of atrial fibrillation/atrial flutter, pulmonary disease, previous stroke, CRP, creatinine, hsTNT and NT-proBNP). The cohort was stratified into 5 quintiles according to this propensity score and the survival time after TAVR was compared within each subgroup. Results: Patients in quintile 5 (n = 93) had the highest likelihood for RI. They were characterized by higher creatinine, lower eGFR, higher NYHA class, higher NT-proBNP, being mostly female and having shorter overall survival time. Within quintile 5, patients without RI had significantly shorter survival compared to patients with RI (p = 0.002, HR = 0.32, 95% CI = [0.15–0.69]). There was no survival time difference between patients with and without RI in the whole cohort (p = 0.12) and in quintiles 1 to 4 (all p > 0.16). Analyses of specific subgroups showed that among patients with NYHA class IV, those with RI also had a significant survival time benefit (p < 0.001, HR = 0.15; 95%-CI = [0.05–0.44]) compared to patients without RI. Conclusions: We here describe a propensity score-derived specific subgroup of patients in which RI after TAVR correlated with a significant survival benefit 
700 1 |a Freitag-Wolf, Sandra  |d 1974-  |e VerfasserIn  |0 (DE-588)129596957  |0 (DE-627)474748049  |0 (DE-576)189352590  |4 aut 
700 1 |a Fulisch, Florian  |e VerfasserIn  |4 aut 
700 1 |a Seoudy, Hatim  |e VerfasserIn  |0 (DE-588)1103493167  |0 (DE-627)861238990  |0 (DE-576)470619651  |4 aut 
700 1 |a Kuhn, Christian  |e VerfasserIn  |0 (DE-588)1172227322  |0 (DE-627)1041002521  |0 (DE-576)514436360  |4 aut 
700 1 |a Kihm, Lars Philipp  |d 1978-  |e VerfasserIn  |0 (DE-588)131796550  |0 (DE-627)514262087  |0 (DE-576)298757346  |4 aut 
700 1 |a Pühler, Thomas  |d 1970-  |e VerfasserIn  |0 (DE-588)124528678  |0 (DE-627)363399291  |0 (DE-576)187806578  |4 aut 
700 1 |a Lutter, Georg  |e VerfasserIn  |0 (DE-588)141244666  |0 (DE-627)625823281  |0 (DE-576)322967694  |4 aut 
700 1 |a Dempfle, Astrid  |d 1975-  |e VerfasserIn  |0 (DE-588)132495074  |0 (DE-627)522966799  |0 (DE-576)299182622  |4 aut 
700 1 |a Frey, Norbert  |e VerfasserIn  |0 (DE-588)141244976  |0 (DE-627)625824075  |0 (DE-576)322969514  |4 aut 
700 1 |a Feldkamp, Thorsten  |d 1973-  |e VerfasserIn  |0 (DE-588)123568927  |0 (DE-627)082634734  |0 (DE-576)186022271  |4 aut 
700 1 |a Frank, Derk  |d 1976-  |e VerfasserIn  |0 (DE-588)129342904  |0 (DE-627)394257413  |0 (DE-576)297610252  |4 aut 
773 0 8 |i Enthalten in  |t BMC nephrology  |d London : BioMed Central, 2000  |g 22(2021), Artikel-ID 77, Seite 1-9  |h Online-Ressource  |w (DE-627)326643672  |w (DE-600)2041348-8  |w (DE-576)107014629  |x 1471-2369  |7 nnas  |a Improvement of renal function after transcatheter aortic valve replacement and its impact on survival 
773 1 8 |g volume:22  |g year:2021  |g elocationid:77  |g pages:1-9  |g extent:9  |a Improvement of renal function after transcatheter aortic valve replacement and its impact on survival 
856 4 0 |u https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-021-02274-5  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://doi.org/10.1186/s12882-021-02274-5  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210831 
993 |a Article 
994 |a 2021 
998 |g 141244976  |a Frey, Norbert  |m 141244976:Frey, Norbert  |d 910000  |d 910100  |e 910000PF141244976  |e 910100PF141244976  |k 0/910000/  |k 1/910000/910100/  |p 10 
998 |g 131796550  |a Kihm, Lars Philipp  |m 131796550:Kihm, Lars Philipp  |d 910000  |d 910100  |d 50000  |e 910000PK131796550  |e 910100PK131796550  |e 50000PK131796550  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 6 
999 |a KXP-PPN1768144702  |e 3972048378 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Dominik","display":"Kylies, Dominik","role":"aut","family":"Kylies"},{"family":"Freitag-Wolf","role":"aut","display":"Freitag-Wolf, Sandra","given":"Sandra"},{"given":"Florian","display":"Fulisch, Florian","role":"aut","family":"Fulisch"},{"display":"Seoudy, Hatim","given":"Hatim","family":"Seoudy","role":"aut"},{"role":"aut","family":"Kuhn","display":"Kuhn, Christian","given":"Christian"},{"family":"Kihm","role":"aut","given":"Lars Philipp","display":"Kihm, Lars Philipp"},{"given":"Thomas","display":"Pühler, Thomas","family":"Pühler","role":"aut"},{"display":"Lutter, Georg","given":"Georg","role":"aut","family":"Lutter"},{"display":"Dempfle, Astrid","given":"Astrid","family":"Dempfle","role":"aut"},{"role":"aut","family":"Frey","display":"Frey, Norbert","given":"Norbert"},{"display":"Feldkamp, Thorsten","given":"Thorsten","role":"aut","family":"Feldkamp"},{"family":"Frank","role":"aut","display":"Frank, Derk","given":"Derk"}],"recId":"1768144702","note":["Gesehen am 31.08.2021"],"name":{"displayForm":["Dominik Kylies, Sandra Freitag-Wolf, Florian Fulisch, Hatim Seoudy, Christian Kuhn, Lars Philipp Kihm, Thomas Pühler, Georg Lutter, Astrid Dempfle, Norbert Frey, Thorsten Feldkamp and Derk Frank"]},"language":["eng"],"relHost":[{"disp":"Improvement of renal function after transcatheter aortic valve replacement and its impact on survivalBMC nephrology","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"year":"2021","volume":"22","pages":"1-9","extent":"9","text":"22(2021), Artikel-ID 77, Seite 1-9"},"note":["Gesehen am 20. Januar 2016"],"pubHistory":["1.2000 -"],"title":[{"title":"BMC nephrology","title_sort":"BMC nephrology"}],"id":{"eki":["326643672"],"issn":["1471-2369"],"zdb":["2041348-8"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedDisp":"2000-","publisher":"BioMed Central","publisherPlace":"London","dateIssuedKey":"2000"}],"recId":"326643672"}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"02 March 2021"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Improvement of renal function after transcatheter aortic valve replacement and its impact on survival","title":"Improvement of renal function after transcatheter aortic valve replacement and its impact on survival"}],"id":{"eki":["1768144702"],"doi":["10.1186/s12882-021-02274-5"]},"physDesc":[{"extent":"9 S."}]} 
SRT |a KYLIESDOMIIMPROVEMEN0220